ALPHA TEKNOVA, INC. Payments for Repurchase of Redeemable Convertible Preferred Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- ALPHA TEKNOVA, INC. payments for repurchase of redeemable convertible preferred stock for fiscal 2021 was $300.00K.
- ALPHA TEKNOVA, INC. payments for repurchase of redeemable convertible preferred stock for fiscal 2020 was $0.00.
| Period end | Payments for Repurchase of Redeemable Convertible Preferred Stock 3 month | Payments for Repurchase of Redeemable Convertible Preferred Stock 12 month |
|---|---|---|
| 2021-12-31 | $300.00K 10-K · filed 2022-03-18 | |
| 2020-12-31 | $0.00 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |